BRL 16.8
(-5.46%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | 7.53 Billion BRL | 9.04% |
2022 | 6.9 Billion BRL | 34.9% |
2021 | 5.11 Billion BRL | 544.97% |
2020 | 793.73 Million BRL | 194.94% |
2019 | -836.02 Million BRL | 21.32% |
2018 | -1.06 Billion BRL | -25.58% |
2017 | -846.14 Million BRL | -90.66% |
2016 | -443.8 Million BRL | -120.16% |
2015 | 2.2 Billion BRL | -27.51% |
2014 | 3.03 Billion BRL | 4.06% |
2013 | 2.91 Billion BRL | 0.0% |
2012 | - BRL | -100.0% |
2011 | 2.74 Billion BRL | 407.53% |
2010 | 540.79 Million BRL | -68.58% |
2009 | 1.72 Billion BRL | 484.26% |
2008 | 294.6 Million BRL | -69.92% |
2007 | 979.54 Million BRL | 433.52% |
2006 | 183.6 Million BRL | 41.23% |
2005 | 130 Million BRL | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q2 | 7.49 Billion BRL | -1.01% |
2024 Q1 | 7.57 Billion BRL | 0.56% |
2023 Q3 | 7.79 Billion BRL | -0.73% |
2023 FY | 7.53 Billion BRL | 9.04% |
2023 Q2 | 7.85 Billion BRL | -0.02% |
2023 Q1 | 7.85 Billion BRL | 13.79% |
2023 Q4 | 7.53 Billion BRL | -3.44% |
2022 FY | 6.81 Billion BRL | 34.9% |
2022 Q1 | 6.71 Billion BRL | 29.71% |
2022 Q3 | 6.74 Billion BRL | 1.44% |
2022 Q2 | 6.65 Billion BRL | -0.96% |
2022 Q4 | 6.9 Billion BRL | 2.34% |
2021 Q2 | 4.62 Billion BRL | -7.88% |
2021 Q3 | 4.36 Billion BRL | -5.76% |
2021 Q4 | 5.17 Billion BRL | 18.74% |
2021 FY | 5.11 Billion BRL | 544.97% |
2021 Q1 | 5.02 Billion BRL | 507.23% |
2020 FY | 847.97 Million BRL | 194.94% |
2020 Q4 | 827.17 Million BRL | 23.26% |
2020 Q1 | -191.34 Million BRL | 76.55% |
2020 Q2 | -323.94 Million BRL | -69.3% |
2020 Q3 | 671.07 Million BRL | 307.15% |
2019 Q2 | -636.01 Million BRL | -212.0% |
2019 Q1 | 567.87 Million BRL | 153.44% |
2019 FY | -836.02 Million BRL | 21.32% |
2019 Q4 | -815.99 Million BRL | -0.15% |
2019 Q3 | -814.8 Million BRL | -28.11% |
2018 FY | -1.06 Billion BRL | -25.58% |
2018 Q4 | -1.06 Billion BRL | -7.38% |
2018 Q3 | -989.53 Million BRL | -35.04% |
2018 Q2 | -732.77 Million BRL | -58.32% |
2018 Q1 | -462.83 Million BRL | 45.3% |
2017 Q4 | -846.13 Million BRL | -13.98% |
2017 Q3 | -742.34 Million BRL | 48.85% |
2017 Q2 | -1.45 Billion BRL | -13.06% |
2017 Q1 | -1.28 Billion BRL | -189.24% |
2017 FY | -846.13 Million BRL | -90.66% |
2016 Q3 | 201.99 Million BRL | 120.83% |
2016 FY | -440.44 Million BRL | -120.16% |
2016 Q4 | -443.8 Million BRL | -319.71% |
2016 Q2 | 91.47 Million BRL | -30.93% |
2016 Q1 | 132.43 Million BRL | -93.98% |
2015 Q2 | 3.4 Billion BRL | -1.06% |
2015 FY | 2.2 Billion BRL | -27.51% |
2015 Q4 | 2.2 Billion BRL | -43.0% |
2015 Q3 | 3.86 Billion BRL | 13.35% |
2015 Q1 | 3.44 Billion BRL | 13.4% |
2014 Q4 | 3.03 Billion BRL | 5.38% |
2014 Q3 | 2.88 Billion BRL | 5.4% |
2014 Q2 | 2.73 Billion BRL | -3.61% |
2014 FY | 3.03 Billion BRL | 4.06% |
2014 Q1 | 2.83 Billion BRL | -2.8% |
2013 Q1 | 2.6 Billion BRL | 0.0% |
2013 Q2 | 2.81 Billion BRL | 8.38% |
2013 Q3 | 2.79 Billion BRL | -0.9% |
2013 Q4 | 2.91 Billion BRL | 4.47% |
2013 FY | 2.91 Billion BRL | 0.0% |
2012 Q4 | - BRL | -100.0% |
2012 Q1 | 1.98 Billion BRL | -27.61% |
2012 Q2 | 2.12 Billion BRL | 7.03% |
2012 Q3 | 2.53 Billion BRL | 19.23% |
2012 FY | 2.7 Billion BRL | -100.0% |
2011 Q1 | 2.22 Billion BRL | 312.03% |
2011 Q3 | 2.58 Billion BRL | 17.3% |
2011 Q2 | 2.2 Billion BRL | -0.92% |
2011 Q4 | 2.74 Billion BRL | 5.98% |
2011 FY | 2.74 Billion BRL | 407.53% |
2010 Q3 | 1.39 Billion BRL | -23.54% |
2010 FY | 540.79 Million BRL | -68.58% |
2010 Q2 | 1.82 Billion BRL | 59.82% |
2010 Q4 | 540.79 Million BRL | -61.21% |
2010 Q1 | 1.14 Billion BRL | -33.71% |
2009 Q4 | 1.72 Billion BRL | 0.0% |
2009 FY | 1.72 Billion BRL | 484.26% |
2008 FY | 294.6 Million BRL | -69.92% |
2007 FY | 979.54 Million BRL | 433.52% |
2006 FY | 183.6 Million BRL | 41.23% |
2005 FY | 130 Million BRL | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
Blau FarmacĂȘutica S.A. | 572.24 Million BRL | -1215.931% |